.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cipla
Julphar
Express Scripts
Cerilliant
Deloitte
Novartis
Queensland Health
McKinsey
McKesson

Generated: November 22, 2017

DrugPatentWatch Database Preview

TRIESENCE Drug Profile

« Back to Dashboard

Which patents cover Triesence, and what generic Triesence alternatives are available?

Triesence is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-three patent family members in nineteen countries.

The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Pharmacology for TRIESENCE

Medical Subject Heading (MeSH) Categories for TRIESENCE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
TRIESENCE
triamcinolone acetonide
INJECTABLE;INTRAVITREAL022048-001Nov 29, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TRIESENCE
triamcinolone acetonide
INJECTABLE;INTRAVITREAL022048-001Nov 29, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TRIESENCE
triamcinolone acetonide
INJECTABLE;INTRAVITREAL022048-001Nov 29, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TRIESENCE

Country Document Number Estimated Expiration
European Patent Office2262506► Subscribe
Denmark2262506► Subscribe
Australia2009223649► Subscribe
Portugal2262506► Subscribe
Slovenia2262506► Subscribe
World Intellectual Property Organization (WIPO)2009114521► Subscribe
Russian Federation2481842► Subscribe
South Korea101555293► Subscribe
Hong Kong1146464► Subscribe
BrazilPI0909630► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Farmers Insurance
Chinese Patent Office
Moodys
Colorcon
Novartis
Fuji
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot